
Peter A Lane Jr. MD
Pediatric Anemia and Red Blood Cell Hematology
Professor, Pediatrics, Emory University School of Medicine
Join to View Full Profile
35 Jesse Hill Jr Dr SEAtlanta, GA 30303
Phone+1 404-785-9800
Fax+1 404-785-9745
Dr. Lane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1984 - 1987
- University of ColoradoFellowship, Pediatric Hematology/Oncology, 1982 - 1984
- University of ColoradoResidency, Pediatrics, 1978 - 1982
- University of Cincinnati College of MedicineClass of 1978
Certifications & Licensure
- CA State Medical License 1984 - Present
- GA State Medical License 2002 - 2025
- CO State Medical License 1981 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 11 citationsPneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines.Thomas V Adamkiewicz, Marianne E M Yee, Stepy Thomas, Amy Tunali, Kristina W Lai
Blood Advances. 2023-11-14 - 1 citationsSex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease.Rachel Astles, Zihao Liu, Scott E Gillespie, Kristina W Lai, Alexander Maillis
Pain Reports. 2023-09-01 - 6 citationsAre children with sickle cell disease at particular risk from the harmful effects of air pollution? Evidence from a large, urban/peri-urban cohort.Paul E George, Alexander Maillis, Yijing Zhu, Yang Liu, Peter A Lane
Pediatric Blood & Cancer. 2023-05-29
Abstracts/Posters
- Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell DiseasePeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in ProgressPeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Social Vulnerability Is Associated with Emergency Department Dependency in Pediatric Sickle Cell Disease PatientsPeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- These Sisters with Sickle Cell Had Devastating — and Preventable — StrokesMay 23rd, 2021
- These Sisters with Sickle Cell Had Devastating, and Preventable, StrokesMay 23rd, 2021
Grant Support
- Serum Amino Acid Concentrations &Nutrition In Children W/ Sickle Cell DiseaseNational Center For Research Resources1999–2002
- Chronic Transfusion And Therapy For Refractory AnemiasNational Center For Research Resources1994–1995
- Study Of Splenic Function In Sickle Hemoglobin C DiseaseNational Center For Research Resources1994
- Study Of Splenic Function In Sickle-Hemoglobin C DiseaseNational Center For Research Resources1993
- Vitamin K Storage And Requirements In Sick Human NewbornsNational Center For Research Resources1985–1988
- Congenital Hemolytic AnemiasNational Center For Research Resources1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: